Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Scientific Title
A Phase 1/2 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 701 Monotherapy, or in Combination With Pomalidomide, With and Without Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Commercial Sponsor
AMGEN
Summary
Eligible patients will be assigned to one of three experimental treatment arms, in which they will either receive AMG 701 monotherapy or AM 701 in combination with pomalidomide and/or dexamethasone.